Biocentriq Interview
In this video interview, Citeline’s senior editor Jung Won Shin talks to Syed Husain, CEO of the US-based cell therapy CDMO BioCentriq, about the company’s role in parent GC’s growth strategy and business priorities, the cell and gene therapy manufacturing market and his views on the US BIOSECURE Act.